Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | — |
No symptoms or side effects were reported by HCP; HCP reporting that a patient received a dose of improperly stored VARIVAX. Reference TE case #02843001. HCP reported that she did not know the date the excursion occurred, but knows the VARIVAX was administered following the excursion. HCP reported; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 16-JUN-2025, the patient received a dose of improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot # Y019318, has been verified to be valid, expiration 21-NOV-2026) 0.5 mL (route, anatomical location were not reported) as prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date not reported). The health care professional (HCP) reported that she did not know the date the excursion occurred, but knew the Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) was administered following the excursion. No symptoms or side effects were reported. The operator of device was HCP. It was reported that the temperature was 52.2 farenheit (F), it was unknown time frame.
Sterile diluent